Johnson & Johnson (VIE:JNJ)

Market Cap	418.32B
Revenue (ttm)	78.81B
Net Income (ttm)	21.48B
Shares Out	n/a
EPS (ttm)	8.85
PE Ratio	19.47
Forward PE	18.05
Dividend	4.57 (2.59%)
Ex-Dividend Date	Nov 25, 2025

Volume	4
Average Volume	58
Open	173.62
Previous Close	173.98
Day's Range	173.62 - 173.98
52-Week Range	128.32 - 179.56
Beta	n/a
RSI	58.29
Earnings Date	Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Pharmaceutical Preparations
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD